Nifty Next 50Healthcarenifty next 50
Torrent Pharmaceuticals Share Price & Analysis
Torrent Pharma is a leading Indian pharma company with strengths in cardiovascular and CNS therapies.
Live price
TORNTPHARM · Healthcare
₹4,550.60
−74.40 (−1.61%)
Day High
₹4,597.10
Day Low
₹4,486.60
52W High
₹5,250.00
52W Low
₹3,532.60
Volume today: 1.10 L
Key fundamentals
Market cap
—
P/E ratio
—
P/B ratio
—
ROE
—
Debt / Equity
—
Dividend yield
—
Revenue growth
—
Earnings growth
—
Live fundamentals from Yahoo Finance where available. Reference ratios may lag the latest quarterly results.
PaisaTamil Consensus
HOLDScore 64/100 · Medium confidence
Mixed signals across valuation and momentum. Existing investors may hold; new entries should wait for clarity.
12M Price Target
₹5,006
Low ₹4,460 · High ₹5,688
Analyst-style Breakdown
Strong Buy
0
Buy
3
Hold
22
Sell
0
Strong Sell
0
Derived from public market signals — price momentum, earnings trend, valuation, quality, and technical position — modelled in an analyst-style consensus format.
Signal Breakdown
Price Momentum85/100
1M -5.0%, 1Y +28.4%
Earnings Trend80/100
Latest quarter revenue ₹4.9k Cr, profit ₹534 Cr
Valuation50/100
P/E — vs sector median ~35x
Financial Quality28/100
ROE —, ROCE —
Technical Position55/100
Trading between 52W low 3533 and high 5250
Modelled from public market signals — not live broker analyst data. For education only; not SEBI-registered investment advice.
Price Chart
Quarterly Results
| Quarter | Revenue | Net Profit | EPS | Rev YoY | Profit YoY |
|---|---|---|---|---|---|
| Sept 2026 | ₹4.9k Cr | ₹534 Cr | ₹14.05 | +50.8% | -9.6% |
| Jun 2026 | ₹4.8k Cr | ₹566 Cr | ₹14.87 | — | — |
| Mar 2026 | ₹4.1k Cr | ₹389 Cr | ₹11.51 | — | — |
| Dec 2025 | ₹3.3k Cr | ₹635 Cr | ₹18.77 | — | — |
| Sept 2025 | ₹3.2k Cr | ₹591 Cr | ₹17.45 | — | — |
Reference Ratios
Market Capⓘ
—
P/E Ratioⓘ
—
P/B Ratioⓘ
—
ROEⓘ
—
ROCEⓘ
—
Div Yieldⓘ
—
Company Overview
Sells branded generics in India and regulated markets with a focus on chronic therapies.
Strengths
- + Strong chronic therapy portfolio in India
- + Consistent profitability and cash generation
Risks
- − USFDA inspection risk at manufacturing sites
- − Price control on select molecules in India
Latest News
No recent news articles for Torrent Pharmaceuticals yet. Check back after the next hourly scan.
Browse all market news →Investor Questions
Yes. Torrent Pharmaceuticals is a current constituent of the Nifty Next 50, which represents the 50 largest Nifty 100 companies outside the Nifty 50.